RYAN SPECIALTY HOLDINGS, INC.·4

Apr 30, 6:19 PM ET

CORTEZI NICHOLAS DOMINIC 4

4 · RYAN SPECIALTY HOLDINGS, INC. · Filed Apr 30, 2026

Research Summary

AI-generated summary of this filing

Updated

Ryan Specialty (RYAN) Director Nicholas Cortezi Receives 5,757-Share Award

What Happened

  • Nicholas Dominic Cortezi, a director of Ryan Specialty Holdings, received a grant of 5,757 Restricted Stock Units (RSUs) on 2026-04-28. The award was recorded at $0.00 (no cash paid) and the RSUs vested immediately upon grant.
  • The reporting form notes Cortezi elected to defer settlement of the vested RSUs until his separation from service on the board. The grant was approved by the Board for purposes of Rule 16(b)(3).

Key Details

  • Transaction date: 2026-04-28; transaction type: Award/Grant (code A); price reported: $0.00; shares/units: 5,757.
  • Total reported value at grant: $0 (no cash purchase).
  • Shares owned after transaction: not specified in the provided filing.
  • Footnotes: F1 — RSUs vested immediately but settlement is deferred until separation from service; F2 — grant approved by the Board for Rule 16(b)(3).
  • Filing: Form 4 filed 2026-04-30 for a 2026-04-28 transaction (filed within the typical two-business-day window).

Context

  • These were restricted stock units (compensation), not an open-market buy or sale. Because settlement is deferred, Cortezi did not receive actual shares at grant time — this is a compensation award rather than a direct investment decision.
  • Such grants are common for directors and do not by themselves indicate a buy/sell signal; they reflect compensation and board-approved awards.

Insider Transaction Report

Form 4
Period: 2026-04-28
Transactions
  • Award

    Class A Common Stock

    [F1][F2]
    2026-04-28+5,75710,777 total
Footnotes (2)
  • [F1]The reported securities represent Restricted Stock Units that vested immediately upon grant for which the reporting person has elected to defer settlement until their separation from service on the board of directors.
  • [F2]The grant was approved by the Board of the Issuer for purposes of Rule 16(b)(3).
Signature
/s/ Mark S. Katz, as Attorney-in-Fact|2026-04-30

Documents

1 file
  • 4
    wk-form4_1777587592.xmlPrimary

    FORM 4